The study of cardiotoxicity of hydroxychloroquine and azithromycine combination in hospitalized patients with COVID-19
Hydroxychloroquine (HCH) is included in guidelines for treatment of novel coronavirus infection (COVID-19). Data on increased risk of cardiovascular complications when using it have been published. Aim. To evaluate the safety and tolerability of HCH and azithromycine (AZM) combination for the treatm...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , |
|---|---|
| Formáid: | Alt |
| Teanga: | Rúisis |
| Foilsithe / Cruthaithe: |
Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
2020-12-01
|
| Sraith: | Сеченовский вестник |
| Ábhair: | |
| Rochtain ar líne: | https://www.sechenovmedj.com/jour/article/view/239 |
| Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|